Carna Health

Carna Health Creating Life-changing Impact in Chronic Kidney Disease with Software and Integrated Point-of-Care Technology.

Carna Health leads healthcare innovation, using advanced technology for real-time kidney disease detection, monitoring, and management. Join us in improving lives through early detection and effective care, creating a healthier community!

We’re heading to ! 🚀Our Chief Operating Officer & Chief Medical Officer, Shika Pappoe, MD, MPH, will be there to discus...
10/18/2024

We’re heading to ! 🚀
Our Chief Operating Officer & Chief Medical Officer, Shika Pappoe, MD, MPH, will be there to discuss how Carna Health’s AI-driven platform is redefining Chronic Kidney Disease management. 💻 Our platform is compliant, secure, and designed to enhance patient outcomes, bringing a new level of care to kidney health.

Curious to learn more about Carna Health and how we’re transforming kidney care?
Let’s connect at HLTH! 🤝

On September 26, the Carna Health team took part in Digital Health Startup Day, co-hosted by the and the Congressional ...
10/14/2024

On September 26, the Carna Health team took part in Digital Health Startup Day, co-hosted by the and the Congressional Digital Health Caucus. It was a huge honor to share what we’ve been working on! 🚀

✨ Highlights from the day:

• Mary Miller Sallah, MHA and Shika Pappoe, MD, MPH showcased our digital health platform at the Health Innovation Showcase, demonstrating how we're transforming CKD care with AI-powered solutions.
• Salvatore Viscomi, MD joined key health policy discussions with Congressional staff, talking about how tech can improve healthcare for everyone.

It was a day full of insightful conversations and a chance to show how Carna Health is leading the way in kidney care.
Huge thanks to everyone who stopped by to learn more about what we do!

💡 Excited for what’s next! Stay tuned as we continue to push boundaries and make a difference in kidney health.

On September 26, the Carna Health team took part in Digital Health Startup Day, co-hosted by the Consumer Technology Ass...
10/14/2024

On September 26, the Carna Health team took part in Digital Health Startup Day, co-hosted by the Consumer Technology Association (CTA) iation and the Congressional Digital Health Caucus. It was a huge honor to share what we’ve been working on! 🚀

✨ Highlights from the day:
• Mary B Miller Sallah, MHA and Shika Pappoe, MD, MPH showcased our digital health platform at the Health Innovation Showcase, demonstrating how we're transforming CKD care with AI-powered solutions.
• Salvatore Viscomi , MD joined key health policy discussions with Congressional staff, talking about how tech can improve healthcare for everyone.

It was a day full of insightful conversations and a chance to show how Carna Health is leading the way in kidney care.
Huge thanks to everyone who stopped by to learn more about what we do!

💡 Excited for what’s next! Stay tuned as we continue to push boundaries and make a difference in kidney health.

Our CEO Salvatore Viscomi recently joined Meg Sinclaire on Qualio’s From Lab to Launch podcast to discuss how Carna Heal...
09/26/2024

Our CEO Salvatore Viscomi recently joined Meg Sinclaire on Qualio’s From Lab to Launch podcast to discuss how Carna Health is shaping the future of kidney care.

Tune in to discover how we're making a global impact by expanding access to screening, advancing early detection, and potentially saving lives through timely interventions.

https://tinyurl.com/2xdtdhuf

On September 26, we're excited to join Congressional staff and industry leaders on Capitol Hill for Digital Health Start...
09/25/2024

On September 26, we're excited to join Congressional staff and industry leaders on Capitol Hill for Digital Health Startup Day, co-hosted by the Consumer Technology Association (CTA) and the Congressional Digital Health Caucus.

Our leadership team, including Mary B Miller Sallah, MHA, Shika Pappoe, MD, MPH, and Salvatore Viscomi, MD, will be showcasing Carna Health's digital health platform at the Health Innovation Showcase. They'll also participate in key discussions with Congressional policymakers, addressing the future of digital healthcare and the role of innovation in Chronic Kidney Disease (CKD) management.

You'll get a firsthand look at how Carna Health is addressing Chronic Kidney Disease (CKD) with cutting-edge technology that connects patients, care teams, and physicians for better outcomes

Join us in shaping the future of healthcare!
🔗 Learn more about the event and RSVP here: https://www.cta.tech/Topics/Digital-Health

Exciting news! Carna Health has been selected to participate in the Digital Health Startup Day in Washington D.C. on Sep...
09/12/2024

Exciting news! Carna Health has been selected to participate in the Digital Health Startup Day in Washington D.C. on September 26th, co-hosted by the Consumer Technology Association (CTA) and the Congressional Digital Health Caucus.

At the Health Innovation Showcase, we’ll be presenting our innovative solutions for CKD management to key industry leaders, including Congressional staff, Members of Congress, and the press. Following the showcase, we’ll participate in an afternoon of in-depth programming and a networking reception, dedicated to connecting with fellow innovators.

We look forward to showcasing our solutions and connecting with others who are transforming healthcare through digital innovation. Stay tuned for updates and highlights from the event! 🎯

Carna Health is proud to partner with Nova Biomedical to bring you state-of-the-art healthcare technology through the No...
09/05/2024

Carna Health is proud to partner with Nova Biomedical to bring you state-of-the-art healthcare technology through the Nova Max Pro Creatinine device. Designed for both risk-based and population-wide health screenings, this device empowers healthcare providers to perform fast and accurate diagnostics, improving patient care outcomes.

🔍 What It Offers:
• Capillary blood testing
• Urine analysis
• Vital sign monitoring

With lab-quality results right at your fingertips, our devices make proactive health management simpler and more accessible. We're empowering healthcare providers to deliver faster, more accurate diagnostics, leading to better health outcomes for all.

💡 Did you know that in the United States, the annual cost of treating end-stage kidney disease (ESKD) can be as high as ...
09/03/2024

💡 Did you know that in the United States, the annual cost of treating end-stage kidney disease (ESKD) can be as high as USD 100,000 per person? This staggering figure contrasts sharply with the USD 16,995 to USD 30,000 needed for managing early-stage chronic kidney disease (CKD).

Early detection and proactive treatment of CKD are not just about cost savings—they are about lives improved and complications prevented. When CKD is caught early, patients can avoid the physical and emotional toll of advanced kidney disease. They can stay healthier, longer, and avoid the extensive treatments that come with .

Investing in early management means fewer hospital visits, less time in dialysis, and more time living life to the fullest. Let's raise awareness and advocate for early CKD screening and intervention. It's a decision that makes financial sense and, more importantly, a decision that profoundly impacts lives.

Join us in spreading the word about the importance of early CKD management. Together, we can make a difference. 💚

08/22/2024

💡Digital AI-Enabled Platform: Bridging the Gap Between Data and Care

Carna Health's platform integrates AI with healthcare, featuring the Carna Patient App, Care Team App, and Physician Portal for seamless data sharing and enhanced decision-making.

📊 Key Aspects:
• Secure device connectivity and real-time data transmission
• Comprehensive data integration
• Advanced data algorithms

Enhance patient management and personalize healthcare with Carna Health.

Experience personalized healthcare like never before.

Carna Health is up for leading two important panels at SXSW, with Dr. Salvatore Viscomi and Dr. Shika Pappoe at the fore...
08/16/2024

Carna Health is up for leading two important panels at SXSW, with Dr. Salvatore Viscomi and Dr. Shika Pappoe at the forefront. But we need your vote to make it happen! 🚀

🗳️ How to Vote:
• Click the "Upvote" button on the top right of each submission.
• Don’t have a SXSW account? No worries—creating one with your email is quick and easy.

🔗 SXSW: https://panelpicker.sxsw.com/vote/154919
🔗 SXSW EDU: https://panelpicker.sxsw.com/vote/155011

📅 Deadline: Just 2 days left to cast your vote! (Voting ends Aug 18, 2024)

Let’s bring Carna Health's life-changing work to the SXSW stage and amplify the voices of Dr. Viscomi and Dr. Pappoe. Together, we can make a real difference. Thank you for your support! 💪

The comprehensive IMPACT CKD analysis by predicts that by 2032, up to 16.5% of the population across key global regions...
08/13/2024

The comprehensive IMPACT CKD analysis by predicts that by 2032, up to 16.5% of the population across key global regions (United States, Brazil, the United Kingdom, Spain, Germany, the Netherlands, China, and Australia) will suffer from chronic kidney disease (CKD), with advanced-stage cases potentially rising by 59.3%. These projections highlight a growing global health crisis with significant economic and environmental implications.🚨

At Carna Health, we are dedicated to changing this trajectory. Our advanced digital health platform and innovative point-of-care technology enable early detection and effective management of CKD. By integrating clinical-grade devices with seamless data connectivity, we empower healthcare providers and patients to take proactive steps towards better health outcomes.📱📊

Our efforts align with AstraZeneca’s Accelerating Change Together (ACT) for CKD initiative, which aims to reduce the progression to kidney failure by at least 20% by 2025 through increased awareness, early detection, and optimized treatment.📉

Connect with Our Innovations: https://carna.health/ (Link in bio)

The comprehensive IMPACT CKD analysis by predicts that by 2032, up to 16.5% of the population across key global regions...
08/13/2024

The comprehensive IMPACT CKD analysis by predicts that by 2032, up to 16.5% of the population across key global regions (United States, Brazil, the United Kingdom, Spain, Germany, the Netherlands, China, and Australia) will suffer from chronic kidney disease (CKD), with advanced-stage cases potentially rising by 59.3%. These projections highlight a growing global health crisis with significant economic and environmental implications.🚨

At Carna Health, we are dedicated to changing this trajectory. Our advanced digital health platform and innovative point-of-care technology enable early detection and effective management of CKD. By integrating clinical-grade devices with seamless data connectivity, we empower healthcare providers and patients to take proactive steps towards better health outcomes.📱📊

Our efforts align with AstraZeneca's Accelerating Change Together (ACT) for CKD initiative, which aims to reduce the progression to kidney failure by at least 20% by 2025 through increased awareness, early detection, and optimized treatment.📉

Connect with Our Innovations: https://carna.health/

Address

131 Dartmouth Street, 3rd Floor
Boston, MA
MA02116

Website

Alerts

Be the first to know and let us send you an email when Carna Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category